Our previous steatosis adverse outcome pathway-based analysis of the same dataset revealed that Cyp7a1 decreased specifically in males [32]; however, the metabolic network analysis in this study predicted that females also showed a decrease in bile acid metabolism. The gene discussed is CYP7A1; the disease is steatosis.